Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jul 09 2021

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-09-2021-6

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 09, 2021, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Erlotinib Tablets, 25 mg, 100 mg, and 150 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases